1. Home
  2. QTTB vs PLSM Comparison

QTTB vs PLSM Comparison

Compare QTTB & PLSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

HOLD

Current Price

$4.69

Market Cap

44.3M

Sector

Health Care

ML Signal

HOLD

PLSM

Pulsenmore Ltd. Ordinary Shares

N/A

Current Price

$5.25

Market Cap

38.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QTTB
PLSM
Founded
2015
2014
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.3M
38.5M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
QTTB
PLSM
Price
$4.69
$5.25
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
156.4K
7.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
100.00
N/A
52 Week Low
$1.38
$5.10
52 Week High
$6.37
$6.85

Technical Indicators

Market Signals
Indicator
QTTB
PLSM
Relative Strength Index (RSI) 57.02 30.34
Support Level $3.99 $5.10
Resistance Level $4.36 $6.13
Average True Range (ATR) 0.40 0.33
MACD -0.00 -0.08
Stochastic Oscillator 62.50 9.72

Price Performance

Historical Comparison
QTTB
PLSM

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.

About PLSM Pulsenmore Ltd. Ordinary Shares

Pulsenmore Ltd is engaged in developing portable ultrasound devices for home use. Its ultrasound scanner dock's with patients' smartphones to deliver images that can be created anywhere, stored and forwarded for clinical review, or shared in an online consultation.

Share on Social Networks: